Amneal (AMRX) Stock Surged On A Strategic Move
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) experienced a notable upswing during the weekend session, registering a 7.89% increase to settle at $5.06. This positive trajectory in Amneal’s stock price was precipitated by a strategic agreement. In a recent development, Amneal (AMRX) and BIAL – Portela & Ca. entered into a licensing arrangement, conferring exclusive rights to […]